Form D · Pharmaceuticals
XENOPORT INC
Santa Clara, CA · CIK 0001130591
Offering snapshot reported Nov 20, 2012 · SEC filing
- Reported sold
- $20M Offering amount: $40M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2012 | Initial | $20,000,000 | No comparison | 1 | SEC filing |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-187248
Source: Form D, filed Nov 20, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vincent J. Angotti | Executive |
| Ronald W. Barrett | Director, Executive |
| Gregory T. Bates | Executive |
| Paul L. Berns | Director |
| Gianna M. Bosko | Executive |
| Dennis M. Fenton | Director |
| John G. Freund | Director |
| Catherine J. Friedman | Director |
| William G. Harris | Executive |
| Jeryl L. Hilleman | Director |
| Ernest Mario | Director |
| William J. Rieflin | Director |
| David R. Savello | Executive |
| Wendell Wierenga | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3410 Central Expressway
Santa Clara, CA, 95051
Santa Clara, CA, 95051